Connective Therapeutics biomaterial/skin/wound news

Connective named G. Kirk Raab as its chairman, the third such appointment for the former Genentech Inc. executive in the last two months. Raab's role at Connective will be similar to his position at Shaman Pharmaceuticals Inc. (SHMN) and Oxford GlycoSystems Ltd., physically spending several days per month on Connective's behalf. Raab also is a director for privately held Oclassen Pharmaceuticals. ...